Mitofusin 2 Inhibits Bladder Cancer Cell Proliferation and Invasion Via the Wnt/β-catenin Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Aug 13

PMID 31402945

Citations 21

Authors

Guofu Pang

Qun Xie

Juanjuan Yao

Affiliations

Soon will be listed here.

Abstract

The present study aimed to investigate the biological role of the mitochondrial GTPase mitofusin-2 (MFN2) in bladder cancer. MFN2 mRNA expression in tumor and paired adjacent non-tumor tissues from 8 patients was investigated using reverse transcription-quantitative polymerase chain reaction analysis. Immunohistochemistry was used to investigate MFN2 expression in 117 bladder cancer specimens. The associations of MFN2 expression with clinicopathological parameters were evaluated statistically. In addition, the biological role of MFN2 in the proliferation, migration and invasion of bladder cancer cells was examined. It was identified that MFN2 expression was significantly downregulated in bladder cancer tissues compared with normal tissues. MFN2 expression was associated with tumor stage, tumor grade and lymph node status. Furthermore, patients with low MFN2 expression demonstrated a shorter overall survival time (P=0.025). MFN2 knockdown by small interfering RNA promoted cancer cell proliferation, migration and invasion , and enhanced tumor progression . Mechanistically, MFN2 was revealed to be involved in Wnt/β-catenin signaling. In conclusion, MFN2 may serve as a potential therapeutic target in the treatment of bladder cancer, and the progress of bladder cancer may be delayed by regulating MFN2 expression.

Citing Articles

Leveraging programmed cell death signature to predict clinical outcome and immunotherapy benefits in postoperative bladder cancer.

Wang Y, Zhang Q Sci Rep. 2024; 14(1):22976.

PMID: 39363008 PMC: 11450150. DOI: 10.1038/s41598-024-73571-w.

Chen C, Zhang J, Liu X, Zhuang Q, Lu H, Hou J Transl Androl Urol. 2024; 13(8):1472-1485.

PMID: 39280688 PMC: 11399026. DOI: 10.21037/tau-24-80.

How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review.

Kuang J, Liu H, Feng L, Xue Y, Tang H, Xu P Med Oncol. 2024; 41(10):238.

PMID: 39218840 PMC: 11366726. DOI: 10.1007/s12032-024-02479-2.

Silencing MFN2 Drives WNT/β-catenin Nucleation to Reduce Sorafenib Sensitivity in Hepatocellular Carcinoma Cells.

Zeng C, Shao B, Chen Y, Ding G Curr Med Sci. 2024; 44(4):789-798.

PMID: 38926329 DOI: 10.1007/s11596-024-2879-x.

Mechanical regulation of mitochondrial morphodynamics in cancer cells by extracellular microenvironment.

Lunova M, Jirsa M, Dejneka A, Sullivan G, Lunov O Biomater Biosyst. 2024; 14:100093.

PMID: 38585282 PMC: 10992729. DOI: 10.1016/j.bbiosy.2024.100093.

References

Chen G, Liu N, Zhou A, Tang C, Ma D, Tang J . The role of hypertension-related gene in aortic vascular smooth muscle cells from mice and rats. Chin Med J (Engl). 2002; 114(8):833-6. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Bach D, Pich S, Soriano F, Vega N, Baumgartner B, Oriola J . Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003; 278(19):17190-7. DOI: 10.1074/jbc.M212754200. View

Zuchner S, Mersiyanova I, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali E . Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004; 36(5):449-51. DOI: 10.1038/ng1341. View

Chan D . Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006; 125(7):1241-52. DOI: 10.1016/j.cell.2006.06.010. View

Guo X, Chen K, Guo Y, Liao H, Tang J, Xiao R . Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 2007; 101(11):1113-22. DOI: 10.1161/CIRCRESAHA.107.157644. View

Jin B, Fu G, Pan H, Cheng X, Zhou L, Lv J . Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol. 2010; 28 Suppl 1:S373-80. DOI: 10.1007/s12032-010-9662-5. View

Papanicolaou K, Kikuchi R, Ngoh G, Coughlan K, Dominguez I, Stanley W . Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res. 2012; 111(8):1012-26. PMC: 3518037. DOI: 10.1161/CIRCRESAHA.112.274142. View

Chen Y, Dorn 2nd G . PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science. 2013; 340(6131):471-5. PMC: 3774525. DOI: 10.1126/science.1231031. View

10.

Zhang G, Jin H, Lin X, Chen C, Liu X, Zhang Q . Anti-tumor effects of Mfn2 in gastric cancer. Int J Mol Sci. 2013; 14(7):13005-21. PMC: 3742171. DOI: 10.3390/ijms140713005. View

11.

Bellmunt J, Orsola A, Leow J, Wiegel T, De Santis M, Horwich A . Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014; 25 Suppl 3:iii40-8. DOI: 10.1093/annonc/mdu223. View

12.

Wang W, Xie Q, Zhou X, Yao J, Zhu X, Huang P . Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett. 2014; 358(1):47-58. DOI: 10.1016/j.canlet.2014.12.025. View

13.

Lou Y, Li R, Liu J, Zhang Y, Zhang X, Jin B . Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma. Med Oncol. 2015; 32(4):132. DOI: 10.1007/s12032-015-0515-0. View

14.

Zlatev D, Altobelli E, Liao J . Advances in imaging technologies in the evaluation of high-grade bladder cancer. Urol Clin North Am. 2015; 42(2):147-57, vii. PMC: 4402158. DOI: 10.1016/j.ucl.2015.01.001. View

15.

Ma L, Chang Y, Yu L, He W, Liu Y . Pro-apoptotic and anti-proliferative effects of mitofusin-2 via PI3K/Akt signaling in breast cancer cells. Oncol Lett. 2016; 10(6):3816-3822. PMC: 4665343. DOI: 10.3892/ol.2015.3748. View

16.

Zhou X, Zhang L, Zheng B, Yan Y, Zhang Y, Xie H . MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2. Cancer Sci. 2016; 107(4):424-32. PMC: 4832850. DOI: 10.1111/cas.12904. View

17.

Cui Y, Ma W, Lei F, Li Q, Su Y, Lin X . Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling. J Pathol. 2016; 239(3):297-308. DOI: 10.1002/path.4725. View

18.

Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y . The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy. Onco Targets Ther. 2016; 9:3213-21. PMC: 4892862. DOI: 10.2147/OTT.S98322. View

19.

Abdelwahid E, Li H, Wu J, Irioda A, Carvalho K, Luo X . Endoplasmic reticulum (ER) stress triggers Hax1-dependent mitochondrial apoptotic events in cardiac cells. Apoptosis. 2016; 21(11):1227-1239. PMC: 5189665. DOI: 10.1007/s10495-016-1286-6. View

20.

Cao Y, Meng S, Chen Y, Feng J, Gu D, Yu B . MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion. Nature. 2017; 542(7641):372-376. PMC: 5319402. DOI: 10.1038/nature21077. View